Vimarsana
Biggest News Aggregation in the World

Pfenex Expression Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfenex Expression Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfenex Expression Technology Today - Breaking & Trending Today

Dyadic Announces Change in Board and Management Leadership Roles - Vimarsana News

Dyadic Announces Change in Board and Management Leadership Roles

JUPITER, Fla., March 28, 2024 -- Dyadic International, Inc. , a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and...

Ligand Spins Out and Merges Pelican Subsidiary with Primordial Genetics to Form Primrose Bio - Vimarsana News

Ligand Spins Out and Merges Pelican Subsidiary with Primordial Genetics to Form Primrose Bio

Ligand retains all Pelican commercial royalties and will own 49.9% of Primrose Bio, Inc. as a stand-alone private company with leading technologies in synthetic biologyLigand contributes $15 million in exchange for economic interest in select Primrose programsLigand improves cash expense outlook and raises EPS guida...

Introducing Primrose Bio: Enabling Innovative Therapeutic Discovery and Manufacturing - Vimarsana News

Introducing Primrose Bio: Enabling Innovative Therapeutic Discovery and Manufacturing

/PRNewswire/ -- Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing state-of-the-art discovery and production systems for...

iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer - Vimarsana News

iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer

[December 28, 2020] iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer BRYAN, Texas, Dec. 28, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the appointment of Martin B. Brenner, DVM, Ph.D., as its Chief Scientific Officer (“CSO”), effective January 18, 2020. “We are thrilled to have Dr. Brenner join our team,” said Tom Isett, Chairman & CEO of iBio. “Given his prior experience leading organizations with novel protein exp...

Source: tmcnet.com